Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 33 studies | 37% ± 16% | |
pericyte | 32 studies | 39% ± 17% | |
smooth muscle cell | 26 studies | 35% ± 14% | |
fibroblast | 21 studies | 33% ± 11% | |
endothelial cell of lymphatic vessel | 15 studies | 37% ± 17% | |
astrocyte | 15 studies | 34% ± 14% | |
glutamatergic neuron | 12 studies | 61% ± 23% | |
microglial cell | 12 studies | 35% ± 11% | |
GABAergic neuron | 11 studies | 48% ± 25% | |
macrophage | 11 studies | 31% ± 13% | |
epithelial cell | 10 studies | 34% ± 15% | |
oligodendrocyte precursor cell | 10 studies | 33% ± 10% | |
adipocyte | 10 studies | 53% ± 18% | |
type I pneumocyte | 9 studies | 26% ± 11% | |
endothelial cell of artery | 9 studies | 22% ± 4% | |
capillary endothelial cell | 9 studies | 25% ± 8% | |
basal cell | 9 studies | 28% ± 13% | |
oligodendrocyte | 9 studies | 26% ± 12% | |
vein endothelial cell | 8 studies | 26% ± 15% | |
endothelial cell of vascular tree | 8 studies | 29% ± 15% | |
neuron | 7 studies | 46% ± 18% | |
interneuron | 6 studies | 54% ± 22% | |
myeloid cell | 6 studies | 23% ± 5% | |
ciliated cell | 6 studies | 28% ± 9% | |
myofibroblast cell | 6 studies | 30% ± 14% | |
type II pneumocyte | 6 studies | 22% ± 7% | |
connective tissue cell | 6 studies | 27% ± 14% | |
retinal cone cell | 5 studies | 29% ± 11% | |
retina horizontal cell | 5 studies | 31% ± 14% | |
monocyte | 5 studies | 23% ± 4% | |
goblet cell | 5 studies | 40% ± 12% | |
club cell | 5 studies | 28% ± 8% | |
abnormal cell | 4 studies | 33% ± 24% | |
granule cell | 4 studies | 48% ± 8% | |
retinal ganglion cell | 4 studies | 26% ± 1% | |
cardiac muscle cell | 4 studies | 22% ± 0% | |
dendritic cell | 4 studies | 22% ± 3% | |
lymphocyte | 4 studies | 29% ± 4% | |
retinal rod cell | 4 studies | 27% ± 7% | |
muscle cell | 4 studies | 40% ± 10% | |
mesothelial cell | 4 studies | 43% ± 14% | |
hepatic stellate cell | 3 studies | 46% ± 18% | |
hematopoietic precursor cell | 3 studies | 18% ± 2% | |
GABAergic interneuron | 3 studies | 48% ± 1% | |
glial cell | 3 studies | 31% ± 5% | |
progenitor cell | 3 studies | 28% ± 5% | |
plasma cell | 3 studies | 24% ± 4% | |
Mueller cell | 3 studies | 24% ± 6% | |
secretory cell | 3 studies | 20% ± 2% | |
hepatocyte | 3 studies | 48% ± 21% | |
ependymal cell | 3 studies | 41% ± 11% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 19% ± 2% | |
adventitial cell | 3 studies | 23% ± 8% | |
T cell | 3 studies | 20% ± 2% | |
alveolar macrophage | 3 studies | 34% ± 11% | |
mast cell | 3 studies | 23% ± 5% | |
erythroblast | 3 studies | 21% ± 3% | |
renal principal cell | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5704.28 | 1443 / 1445 | 100% | 33.53 | 183 / 183 |
intestine | 100% | 5452.92 | 966 / 966 | 100% | 34.49 | 526 / 527 |
bladder | 100% | 8867.29 | 21 / 21 | 100% | 23.26 | 502 / 504 |
lung | 100% | 7355.55 | 578 / 578 | 100% | 23.21 | 1150 / 1155 |
uterus | 100% | 8073.46 | 170 / 170 | 99% | 20.46 | 456 / 459 |
breast | 100% | 9633.76 | 459 / 459 | 99% | 24.18 | 1108 / 1118 |
prostate | 100% | 4827.92 | 244 / 245 | 99% | 18.38 | 498 / 502 |
stomach | 99% | 3508.84 | 356 / 359 | 99% | 35.36 | 284 / 286 |
ovary | 100% | 4505.96 | 180 / 180 | 98% | 13.41 | 423 / 430 |
thymus | 100% | 3998.35 | 651 / 653 | 98% | 14.15 | 594 / 605 |
brain | 98% | 4071.24 | 2584 / 2642 | 100% | 21.94 | 704 / 705 |
liver | 98% | 2106.25 | 221 / 226 | 97% | 13.70 | 393 / 406 |
kidney | 99% | 2744.11 | 88 / 89 | 96% | 19.55 | 862 / 901 |
skin | 100% | 4675.54 | 1806 / 1809 | 91% | 17.74 | 431 / 472 |
adrenal gland | 99% | 2873.94 | 256 / 258 | 90% | 10.08 | 206 / 230 |
pancreas | 89% | 1645.86 | 291 / 328 | 99% | 21.93 | 177 / 178 |
adipose | 100% | 11478.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10262.13 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7559.31 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4822.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.59 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 97% | 9.76 | 28 / 29 |
heart | 95% | 3045.09 | 817 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 71% | 7.07 | 57 / 80 |
peripheral blood | 24% | 633.13 | 222 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006939 | Biological process | smooth muscle contraction |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0010825 | Biological process | positive regulation of centrosome duplication |
GO_1903347 | Biological process | negative regulation of bicellular tight junction assembly |
GO_0071559 | Biological process | response to transforming growth factor beta |
GO_0070168 | Biological process | negative regulation of biomineral tissue development |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_1902993 | Biological process | positive regulation of amyloid precursor protein catabolic process |
GO_2000145 | Biological process | regulation of cell motility |
GO_0006468 | Biological process | protein phosphorylation |
GO_0048511 | Biological process | rhythmic process |
GO_1900037 | Biological process | regulation of cellular response to hypoxia |
GO_0002931 | Biological process | response to ischemia |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0035509 | Biological process | negative regulation of myosin-light-chain-phosphatase activity |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_1902966 | Biological process | positive regulation of protein localization to early endosome |
GO_0032723 | Biological process | positive regulation of connective tissue growth factor production |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0044788 | Biological process | modulation by host of viral process |
GO_1905145 | Biological process | cellular response to acetylcholine |
GO_0150033 | Biological process | negative regulation of protein localization to lysosome |
GO_1905205 | Biological process | positive regulation of connective tissue replacement |
GO_0051496 | Biological process | positive regulation of stress fiber assembly |
GO_0051298 | Biological process | centrosome duplication |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0003180 | Biological process | aortic valve morphogenesis |
GO_0061157 | Biological process | mRNA destabilization |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0071394 | Biological process | cellular response to testosterone stimulus |
GO_0097746 | Biological process | blood vessel diameter maintenance |
GO_0031032 | Biological process | actomyosin structure organization |
GO_0048598 | Biological process | embryonic morphogenesis |
GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
GO_0051492 | Biological process | regulation of stress fiber assembly |
GO_0051893 | Biological process | regulation of focal adhesion assembly |
GO_0031644 | Biological process | regulation of nervous system process |
GO_1903140 | Biological process | regulation of establishment of endothelial barrier |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_2000114 | Biological process | regulation of establishment of cell polarity |
GO_0110061 | Biological process | regulation of angiotensin-activated signaling pathway |
GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_1901888 | Biological process | regulation of cell junction assembly |
GO_0045019 | Biological process | negative regulation of nitric oxide biosynthetic process |
GO_0090271 | Biological process | positive regulation of fibroblast growth factor production |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0045616 | Biological process | regulation of keratinocyte differentiation |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0007266 | Biological process | Rho protein signal transduction |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0030866 | Biological process | cortical actin cytoskeleton organization |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_1990776 | Biological process | response to angiotensin |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005634 | Cellular component | nucleus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0005829 | Cellular component | cytosol |
GO_0005524 | Molecular function | ATP binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0061133 | Molecular function | endopeptidase activator activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005198 | Molecular function | structural molecule activity |
GO_0002020 | Molecular function | protease binding |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0072518 | Molecular function | Rho-dependent protein serine/threonine kinase activity |
Gene name | ROCK2 |
Protein name | Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) non-specific serine/threonine protein kinase (EC 2.7.11.1) Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (p164 ROCK-2) Rho-associated protein kinase (EC 2.7.11.1) |
Synonyms | KIAA0619 |
Description | FUNCTION: Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. . FUNCTION: Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation. . |
Accessions | ENST00000261535.7 A0A8V8TL90 A0A2P9DU05 A0A8V8TL82 ENST00000697752.1 Q14DU5 ENST00000315872.11 C9JFJ0 E9PF63 D6REE7 ENST00000697790.1 ENST00000401753.5 ENST00000431087.2 O75116 |